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Iliofemoral venous occlusions may sometimes be encoun-
tered in patients with congenital heart disease (CHD),
because of repeated catheterizations, a cut-down of the
femoral vein, insertion of central venous catheters, or
surgical venous anastomoses.1–3 Consequently procedures
for catheter intervention, including catheter ablation, may
sometimes become difﬁcult or impossible because of a
femoral venous occlusion. We report a patient with bilateral
iliofemoral venous occlusions after a Glenn operation
who subsequently underwent a successful radiofrequency
catheter ablation (RFCA) of atrial ﬂutter (AFL) after the
implantation of ileofemoral stents.Case report
A 32-year-old woman was referred to our hospital for RFCA
of AFL. She was diagnosed with pulmonary atresia with an
intact ventricular septum just after her delivery, and under-
went a Blalock-Taussig shunt and Brock operation when she
was 3 months old, right ventricular outlet tract repair at 3
years old, and Glenn operation and closure of an atrial septal
defect at 10 years old. AFL was ﬁrst noted when she was 30
years old. Because 1:1 conduction of the AFL was docu-
mented by Holter monitoring and her daily life was impaired
owing to the tachycardia, RFCA of the AFL was attempted
in a previous hospital, but it was unsuccessful because
catheter insertion into the atrium was impossible owing to
bilateral femoral vein occlusions and a Glenn operation.KEYWORDS Iliofemoral vein obstruction; Adult congenital heart disease;
Glenn operation; Atrial ﬂutter (Heart Rhythm Case Reports 2016;2:138–141)
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control of the AFL and to prevent thromboembolisms. She
was referred to our hospital to undergo a possible RFCA.
On physical examination, an early diastolic murmur
(Levine II/VI) was audible and the jugular vein was over-
distended. There were scars from a surgical cut-down on the
bilateral inguinal regions. An electrocardiogram showed 2:1
conduction of the AFL. An echocardiogram revealed right
atrial and ventricular dilatation, moderate pulmonary regur-
gitation, and mild tricuspid regurgitation (pressure gradient
18 mm Hg); however, there was no shunt between the atrial
septum and ventricular septum. In the blood tests, the
prothrombin time was within normal limits while she was
taking warfarin. The protein C, protein S, and antiphospho-
lipid antibody levels were all within normal limits.
Angiography of the great saphenous veins revealed
that the iliac vein was occluded with the development of
collateral vessels to the inferior vena cava (IVC) (Figure 1A).
After written informed consent was obtained, a recanaliza-
tion procedure and stenting were performed under general
anesthesia. A 7F sheath (Radifocus introducer; Terumo
interventional systems Co Ltd., Japan) was inserted from
the right femoral vein by an echo-guided approach. A 0.035
inch guidewire (Glidewire; Terumo interventional systems
Co Ltd, Japan) was then advanced through the collateral
vessel by guidance with a contrast injection from the sheath,
and advanced to the IVC across the restricted vessel.
Balloon-expandable stents (Palmatz; Cordis Co Ltd, Miami,
FL ) and self-expandable stents (Wall stent; Boston Scientiﬁc
Co Ltd., Marlborough, MA) were implanted one after
another in the stenosed segments (Figure 1B and C) through
the IVC, and from the iliac vein to the femoral vein. After the
stent implantation, the femoral vein was opened and drained
into the IVC (Figure 1D).
After obtaining venous access into the IVC, we performed
an electrophysiologic study and catheter ablation. A stiff
guidewire (Amplatz, Super Stiff; Boston Scientiﬁc Co Ltd,
Marlborough, MA) was advanced through the implantedpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.11.010
KEY TEACHING POINTS
 In this patient, a conventional femoral approach
was difﬁcult because of bilateral iliofemoral vein
occlusions. Moreover, an internal jugular vein
approach would have also been difﬁcult, because of
her postoperative status of a Glenn procedure.
 A stent implantation into an occluded iliofemoral
vein could be an alternative novel method for
performing a radiofrequency catheter ablation.
 Complications involving pulmonary embolization,
infections, and fractures of stents should be noted
after the implantation of stents in the
ileofemoral vein
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Swartz Braided Transseptal Guiding Introducers; St Jude
Medical Co Ltd., Marlborough, MA) was advanced over the
guidewire. Then an 8F catheter (ThermoCool SmartTouch;
Biosense, Webster Co Ltd,) was advanced into the atrium
through the long sheath. Additionally, a conventional sheath
(5F Radifocus introducer; Terumo interventional systems Co
Ltd., Japan) was introduced from the right femoral vein by an
echo-guided approach, and an 4F 20 polar electrode catheter
(EPstar; Japan Lifeline Co Ltd., Japan) was advanced into
the RA under ﬂuoroscopy. The voltage mapping revealed a
low voltage area in an extensive area of the RA. Using a
propagation map, AFL1 was identiﬁed to be a counter-
clockwise macroreentrant AFL around the tricuspid valve.
The postpacing interval during the AFL was consistent with
the AFL cycle length in the area above the scar in the RA and
the area around the tricuspid valve (AFL1). During the linear
ablation from the tricuspid annulus through the IVC (cavo-
tricuspid isthmus), the AFL sequence changed (AFL2)
(Figure 2). AFL2 was ﬁnally terminated by completing the
linear ablation of the cavotricuspid isthmus. Digoxin was
discontinued after the RFCA, and the patient remained in
sinus rhythm with no recurrence of the AFL during a follow-
up of 7 months.Discussion
In this patient, the bilateral iliofemoral veins were occluded
from a surgical operation, cannulation of the catheters, and a
cut-down of the femoral veins.1–3 Systemic vein occlusions
after CHD surgery are not a rare condition. If the iliofemoralveins are occluded, the approach to the intracardiac cham-
bers can be quite difﬁcult. The other option when the femoral
approach is difﬁcult is a superior approach from a Glenn
operation through the pulmonary artery and right ventricle
into the RA. The superior approach via the jugular vein or
azygos vein is an effective method for an IVC deﬁciency and
occluded iliofemoral veins. Thus far the successful ablation
of atrioventricular reentry tachycardia, atrioventricular nodal
reentry tachycardia, and AFL have been reported by a
superior approach.4–7 However, catheter manipulation can
be quite difﬁcult because the catheter has to pass multiple
vessels and cardiac chambers. The second option is a
retrograde approach from the aorta through the left ventricle
and left atrium into the RA;8 however, in this patient it was
impossible because there was no atrial shunt. A transhepatic
approach has been reported in these patients as another
option to reach the RA.9–13 Singh et al10 reported 2 patients
with interrupted IVCs in whom a transhepatic approach was
successfully performed to terminate atrial arrhythmias.
Nguyen et al12 reported that the transhepatic approach is a
safe and feasible method in patients with limited venous
access for a successful ablation of AFL, atrial tachycardia,
and atrioventricular nodal reentry tachycardia. Shim et al13
reported that the complication rate of the transhepatic
approach is o5% in pediatric populations.
Stent implantations were reported to be effective for
occluded veins.14–16 Neglén et al14 reported that the long-
term patency rate was quite satisfactory in 982 limbs with
obstructive iliac vein lesions after implanting stents. To the
best of our knowledge, this is the ﬁrst report of implanted
stents for an occluded iliofemoral vein for the purpose of
catheter ablation. Although we succeeded in creating access
through the femoral vein into the IVC, the number of
catheters was limited because of the stent size and the stent
had no ability to expand.
For the purpose of catheter ablation, implanting stents for
an occluded ileofemoral vein can be an alternative and an
effective and safe procedure. However, the occurrence of
pulmonary embolisms or embolisms of other organs should
be considered during this procedure if there is a right-to-left
shunt with an organized old thrombus while advancing the
guidewire or guiding catheter through the stent.Conclusion
In the case of an iliofemoral venous occlusion after a CHD
operation, a stent implantation into an occluded iliofemoral
Figure 1 Angiogram of the femoral vein before and after implanting the stents.A: Image demonstrates an occluded right iliofemoral vein and the development
of collateral vessels running above to the inferior vena cava (IVC). B:An 0.035-inch guidewire was advanced to the IVC across the restricted vessel.C: Balloon-
expandable stents (Palmatz) were implanted in the stenosed segments through the IVC. D: After the stent implantation, the femoral vein was opened and drained
into the IVC.
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Figure 2 Sequence change during linear ablation of cavotricuspid isthmus. I ¼ lead I; aVF ¼ lead aVF; V1 ¼ lead V1; RA ¼ right atrial electrocardiogram;
MAP ¼ mapping catheter electrocardiogram. AFL ¼ atrial ﬂutter.
141Kumamoto et al Implantation of Ileofemoral Stents for Bilateral Occlusions of the Veinvein could be an alternative novel method for performing
an RFCA.
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